BrightSpring Health Services, Inc. (NASDAQ:BTSG) Expected to Post Q2 2024 Earnings of $0.15 Per Share

BrightSpring Health Services, Inc. (NASDAQ:BTSGFree Report) – Leerink Partnrs increased their Q2 2024 earnings per share estimates for BrightSpring Health Services in a research note issued on Tuesday, May 7th. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings per share of $0.15 for the quarter, up from their prior forecast of $0.14. Leerink Partnrs has a “Outperform” rating on the stock. The consensus estimate for BrightSpring Health Services’ current full-year earnings is $0.67 per share. Leerink Partnrs also issued estimates for BrightSpring Health Services’ Q3 2024 earnings at $0.17 EPS, Q4 2024 earnings at $0.19 EPS, FY2024 earnings at $0.66 EPS, Q1 2025 earnings at $0.18 EPS, Q2 2025 earnings at $0.21 EPS, Q3 2025 earnings at $0.24 EPS, Q4 2025 earnings at $0.26 EPS, FY2025 earnings at $0.88 EPS, FY2026 earnings at $1.11 EPS and FY2027 earnings at $1.35 EPS.

BrightSpring Health Services (NASDAQ:BTSGGet Free Report) last posted its earnings results on Thursday, May 2nd. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.06 by $0.06. The company had revenue of $2.58 billion during the quarter, compared to analysts’ expectations of $2.31 billion. During the same period in the prior year, the business posted ($0.10) earnings per share. The company’s revenue for the quarter was up 27.0% on a year-over-year basis.

Several other research analysts have also recently weighed in on the stock. SVB Leerink started coverage on shares of BrightSpring Health Services in a research note on Tuesday, February 20th. They set an “outperform” rating and a $15.00 price target on the stock. Wells Fargo & Company lifted their price objective on shares of BrightSpring Health Services from $15.00 to $16.00 and gave the company an “overweight” rating in a research report on Monday. Bank of America assumed coverage on BrightSpring Health Services in a research note on Tuesday, February 20th. They set a “buy” rating and a $14.00 price target for the company. Guggenheim started coverage on shares of BrightSpring Health Services in a research report on Tuesday, February 20th. They set a “buy” rating and a $15.00 price objective for the company. Finally, Morgan Stanley began coverage on shares of BrightSpring Health Services in a report on Tuesday, February 20th. They issued an “overweight” rating and a $18.00 target price on the stock. Eleven analysts have rated the stock with a buy rating, Based on data from MarketBeat, BrightSpring Health Services has an average rating of “Buy” and an average price target of $15.85.

Read Our Latest Report on BTSG

BrightSpring Health Services Stock Performance

Shares of BTSG opened at $11.37 on Thursday. BrightSpring Health Services has a fifty-two week low of $7.85 and a fifty-two week high of $12.14. The business has a 50-day simple moving average of $10.06. The company has a debt-to-equity ratio of 5.73, a quick ratio of 0.84 and a current ratio of 1.17.

Institutional Trading of BrightSpring Health Services

A number of institutional investors have recently made changes to their positions in BTSG. BNP Paribas Financial Markets acquired a new stake in BrightSpring Health Services in the first quarter worth about $280,000. Seven Grand Managers LLC acquired a new position in shares of BrightSpring Health Services in the 1st quarter valued at $1,630,000. Finally, Capstone Investment Advisors LLC purchased a new position in BrightSpring Health Services in the 1st quarter worth $9,722,000.

Insider Buying and Selling

In other BrightSpring Health Services news, CAO Jennifer A. Phipps acquired 12,300 shares of the company’s stock in a transaction dated Thursday, March 14th. The shares were purchased at an average cost of $8.14 per share, for a total transaction of $100,122.00. Following the completion of the purchase, the chief accounting officer now owns 165,618 shares in the company, valued at $1,348,130.52. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CAO Jennifer A. Phipps acquired 12,300 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was purchased at an average cost of $8.14 per share, for a total transaction of $100,122.00. Following the purchase, the chief accounting officer now directly owns 165,618 shares of the company’s stock, valued at approximately $1,348,130.52. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider James F. Mattingly, Jr. bought 12,280 shares of the business’s stock in a transaction on Thursday, March 14th. The stock was bought at an average price of $8.18 per share, for a total transaction of $100,450.40. Following the purchase, the insider now directly owns 128,700 shares of the company’s stock, valued at $1,052,766. The disclosure for this purchase can be found here.

About BrightSpring Health Services

(Get Free Report)

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.

Featured Articles

Earnings History and Estimates for BrightSpring Health Services (NASDAQ:BTSG)

Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.